Literature DB >> 26753874

Tissue Levels of Stefin A and Stefin B in Hepatocellular Carcinoma.

Yang-Yuan Lin1, Zhi-Wei Chen2, Zhi-Ping Lin1, Li-Bin Lin1, Xue-Ming Yang1, Li-Yan Xu1, Qun Xie1.   

Abstract

Stefins have been reported to be associated with the progression and metastasis of various malignant tumors. However, the expressions of stefins in hepatocellular carcinoma (HCC) have not been well-defined. In this study, the protein levels of stefin A and stefin B were assessed by immunohistochemical staining, and the mRNA levels were quantified by real-time polymerase chain reaction in 85 primary HCC tissues, 85 surrounding non-cancerous tissues, and 9 normal hepatic tissues. The immunohistochemical staining of cathepsin B and cathepsin D, and the ratio of cathepsins to stefins were assessed. The mRNA expressions of stefin A and stefin B in HCC tissues were significantly higher than surrounding noncancerous tissues and normal hepatic tissues, respectively. A significant positive relationship of stefin A and stefin B was found with node metastasis, tumor size, and Edmondson grade for HCC. Univariate and multivariate analyses revealed that Edmondson grade and stefin B expression were independent factors associated with the risk of lymph node metastasis in HCC. The ratios of cathepsin B to stefin A, cathepsin D to stefin A, cathepsin B to stefin B and cathepsin D to stefin B of the HCC group were significantly higher than that of the surrounding noncancerous group. A significant positive correlation between the ratio of cathepsins to stefins (cathepsin B/stefin A, cathepsin B/stefin B and cathepsin D/stefin B) and node metastasis was demonstrated. We concluded that high expressions of stefin A and stefin B may be an important factor contributing to the development and metastasis of HCC.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  hepatocellular carcinoma; metastasis; stefin A; stefin B

Mesh:

Substances:

Year:  2016        PMID: 26753874     DOI: 10.1002/ar.23311

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  6 in total

1.  Cancer Cell-Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma.

Authors:  Chenxi Tian; Daniel Öhlund; Steffen Rickelt; Tommy Lidström; Ying Huang; Liangliang Hao; Renee T Zhao; Oskar Franklin; Sangeeta N Bhatia; David A Tuveson; Richard O Hynes
Journal:  Cancer Res       Date:  2020-02-06       Impact factor: 12.701

2.  In Silico, In Vitro, and Clinical Investigations of Cathepsin B and Stefin A mRNA Expression and a Correlation Analysis in Kidney Cancer.

Authors:  Magdalena Rudzinska-Radecka; Anastasia S Frolova; Anastasia V Balakireva; Neonila V Gorokhovets; Vadim S Pokrovsky; Darina V Sokolova; Dmitry O Korolev; Natalia V Potoldykova; Andrey Z Vinarov; Alessandro Parodi; Andrey A Zamyatnin
Journal:  Cells       Date:  2022-04-25       Impact factor: 7.666

3.  Site-1 protease ablation in the osterix-lineage in mice results in bone marrow neutrophilia and hematopoietic stem cell alterations.

Authors:  Debabrata Patra; Joongho Kim; Qiang Zhang; Eric Tycksen; Linda J Sandell
Journal:  Biol Open       Date:  2020-06-23       Impact factor: 2.422

4.  Expression of Cathepsin B and Cystatin A in Oral Lichen Planus.

Authors:  Pear Bangsuwan; Worawalun Hirunwidchayarat; Pimporn Jirawechwongsakul; Sineepat Talungchit; Patrayu Taebunpakul
Journal:  J Int Soc Prev Community Dent       Date:  2021-09-21

5.  Clinical features of cystatin A expression in patients with pancreatic ductal adenocarcinoma.

Authors:  Takuya Komura; Hisashi Takabatake; Kenichi Harada; Masatoshi Yamato; Masaki Miyazawa; Keiko Yoshida; Masao Honda; Takashi Wada; Hirohisa Kitagawa; Tetsuo Ohta; Shuichi Kaneko; Yoshio Sakai
Journal:  Cancer Sci       Date:  2017-10-08       Impact factor: 6.716

6.  Identification of Cysteine Protease Inhibitor CST2 as a Potential Biomarker for Colorectal Cancer.

Authors:  Qiurong Xie; Liya Liu; Xiaoping Chen; Ying Cheng; Jiapeng Li; Xiuli Zhang; Nanhui Xu; Yuying Han; Huixin Liu; Lihui Wei; Jun Peng; Aling Shen
Journal:  J Cancer       Date:  2021-06-22       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.